[4] The primary objective of this study was to assess bioequivalence between a new ibuprofen soft gelatin capsule formulation and the standard 200mg sugar-coated tablets. This patented new ...
Bioequivalence between 200mg tablets of ibuprofen lysinate and a new 200mg soft gelatin capsule was demonstrated. In accordance with previous results, this study confirmed again the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results